妊娠糖尿病检测值对婴儿生长和身体组成的影响:随机试验中的前性队列研究
Komal Manerkar1, Caroline A Crowther1, Jane E Harding1
1Liggins Institute, University of Auckland, Auckland, New Zealand.
Diabetes care
|August 29, 2023
概括
较低的妊娠糖尿病 (GDM) 检测值没有增加婴儿脂肪质量. 更高的GDM值也没有显示与婴儿肥胖风险因素增加的相关性.
科学领域:
- 产科和妇科 产科和妇科
- 儿科 儿科 儿科
- 内分泌学 在内分泌学.
背景情况:
- 孕期糖尿病 (GDM) 与后代肥胖症有关.
- 将GDM与婴儿代谢疾病联系在一起的因果因素需要澄清.
研究的目的:
- 评估不同的GDM检测和治疗值如何影响婴儿肥胖风险因素.
- 评估GDM诊断标准对婴儿身体组成,生长,营养和食欲的影响.
主要方法:
- 前性队列研究 (GEMS试验),比较较低GDM诊断标准与较高GDM诊断标准.
- 婴儿根据GDM暴露情况进行分类:未接受治疗,接受较低标准的治疗或接受较高标准的治疗.
- 主要结局:在5-6个月大时全身脂肪量.
主要成果:
- 在对照婴儿和那些根据较低标准 (接受治疗或未接受治疗) 诊断出GDM的婴儿之间,没有观察到婴儿脂肪质量的显著差异.
- 与对照组相比,暴露于GDM并使用更高值检测和治疗的婴儿在脂肪质量上也没有显著差异.
- 调整后的脂肪质量平均差异在各暴露组中从-0.09到-0.17公斤不等.
结论:
- 使用较低标准检测GDM,无论母亲的治疗,都没有与婴儿脂肪质量增加有关.
- 当用于检测和治疗时,更高的GDM诊断值也没有提高5-6个月的婴儿脂肪量.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Pathophysiology of Diabetes
986
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
986
Diabetes: Symptoms, Diagnosis, and Complications
588
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
588
Diabetes Mellitus: Overview and Type I Subtype
2.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Oral Hypoglycemic Agents: Biguanides and Glitazones
230
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
230
Insulin: Dosing Regimen and Adverse Effects
205
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
205


